True Continuous ECG Monitoring (TCEM Study)
TCEM
Comparison of Short Term Holter Monitoring vs. Long Term Zio(R)Patch True Continuous ECG Monitoring (TCEM Study)
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to compare short term (up to 48 hours) traditional cardiac rhythm monitoring using a standard ambulatory Holter monitor versus long term (up to 14 days), continuous ambulatory cardiac rhythm monitoring using a new device cleared by the FDA (Zio® Patch), iRhythm Technologies, Inc., San Francisco CA) in patients with suspected cardiac arrhythmias.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2012
CompletedFirst Posted
Study publicly available on registry
March 21, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedApril 18, 2019
April 1, 2019
7 months
March 9, 2012
April 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Arrhythmia detection for Zio® patch and the traditional ambulatory Holter monitor.
Data will be examined to determine the difference in the number of 6 types of arrhythmias detected at maximum observation times of 14 days and 24 hours respectively. In comparing the difference of the number of arrhythmias for the Zio® Patch and the Holter data, we are expecting a skewed distribution of the differences and will use a paired Wilcoxon Signed Rank Test since the normality assumption is not met for a paired t-test. If the difference is significantly greater than zero, there is evidence that the Zio® Patch is an improvement in this sample.
Up to 14 days.
Secondary Outcomes (1)
Subjects ease in comfort for the Zio® Patch and the traditional ambulatory Holter monitor.
Up to14 days.
Study Arms (1)
Cardiac Arrhythmia
Subjects 18 years of age or greater that have indications for traditional cardiac(Holter) monitoring.
Eligibility Criteria
Patients 18 years of age of greater with suspected arrhythmias.
You may qualify if:
- Are being seen in the outpatient office for evaluation, treatment, or follow-up of arrhythmias;
- Have a medical history for which ascertaining whether asymptomatic arrhythmias is occurring could be helpful in their treatment plan;
- Are capable of giving informed consent; assessed by the investigator or the Study Coordinator;
- Are 18 years of age or older;
- Able to comply with long term continuous monitoring ECG device.
You may not qualify if:
- Have known skin allergies, conditions, or sensitivities (e.g. allergy to adhesives, psoriasis) as the Zio(R)Patch should not be used on patients with known skin allergies, conditions, or sensitivities; or
- Are receiving pacing therapy (e.g., from a pacemaker); or
- Are anticipated to receive or require external cardiac defibrillation during the monitoring period; or
- Are anticipated to be exposed to high frequency surgical equipment during the monitoring period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Scripps Health
La Jolla, California, 92037, United States
Related Publications (1)
Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, Fought AJ, Topol EJ. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014 Jan;127(1):95.e11-7. doi: 10.1016/j.amjmed.2013.10.003. Epub 2013 Oct 15.
PMID: 24384108DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Topol, MD
Scripps Translational Science Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2012
First Posted
March 21, 2012
Study Start
April 1, 2012
Primary Completion
November 1, 2012
Study Completion
December 1, 2012
Last Updated
April 18, 2019
Record last verified: 2019-04